In a significant medical breakthrough, researchers from the Institute of Nano Science and Technology (INST), Mohali, have developed a novel drug delivery system to treat Central Nervous System Tuberculosis (CNS-TB). This cutting-edge method delivers anti-tuberculosis (TB) drugs directly to the brain through the nasal route, overcoming the limitations posed by the blood-brain barrier (BBB).

CNS-TB, a life-threatening condition, impacts the brain and spinal cord, often manifesting as tuberculous meningitis. Symptoms include headaches, fever, neck stiffness, seizures, and neurological impairments. If untreated, CNS-TB can lead to severe complications such as paralysis or death. Traditionally, treating this condition has been challenging due to the BBB, which limits the amount of drug that reaches the brain, thereby reducing treatment efficacy.

Chitosan-Based Nano-Aggregates: A New Frontier in Drug Delivery

Led by Rahul Kumar Verma and a team of researchers including Krishna Jadhav, Agrim Jhilta, Raghuraj Singh, Eupa Ray, Vimal Kumar, Awadh Yadav, and Amit Kumar Singh, the scientists developed chitosan nano-aggregates for efficient nasal drug delivery. These nano-aggregates, composed of clusters of biocompatible and biodegradable chitosan nanoparticles, are specifically designed to carry TB medications such as isoniazid (INH) and rifampicin (RIF).

This innovative system leverages chitosan’s mucoadhesive properties, allowing the nano-aggregates to adhere to the nasal mucosa. This adhesion helps prolong the retention time of the drug, ensuring sustained release and enhanced therapeutic impact. The nose-to-brain delivery approach ensures high bioavailability of the drugs at the infection site, marking a significant advancement in the treatment of CNS-TB.

Broader Applications in Brain Disorders and Neurodegenerative Diseases

According to an official statement from INST, the success of this approach in CNS-TB paves the way for broader clinical applications. “This delivery system could potentially revolutionize treatment for other brain-related conditions such as neurodegenerative diseases, including Alzheimer’s and Parkinson’s, as well as brain tumors and epilepsy by facilitating more effective drug delivery to the brain,” the team stated.

Publication and Industry Impact

The findings have been published in the journal Nanoscale (Royal Society of Chemistry), attracting interest from pharmaceutical and healthcare sectors focused on innovative treatment pathways. This development offers new opportunities for B2B stakeholders, including drug manufacturers, R&D organizations, and biotech firms, to explore collaborative avenues in nanotechnology-based healthcare solutions.

Also Read: Dengue Outbreak Worsens in Lucknow: 1115 Cases Reported, Health Department Intensifies Measures

Implications for the Healthcare Industry

This breakthrough comes at a critical time when CNS-TB and other complex brain diseases demand innovative interventions. The nose-to-brain delivery model can reduce treatment timelines and improve patient outcomes by ensuring drugs reach their intended targets efficiently. Moreover, the research aligns with growing trends toward personalized medicine, targeted therapies, and the use of nanotechnology in healthcare.

With the potential to enhance the efficacy of brain disease treatments and transform patient care, this innovation highlights the importance of cross-disciplinary collaboration between nanotechnology, pharmaceuticals, and healthcare delivery systems. As the technology evolves, it is poised to set new benchmarks in CNS-TB management and beyond, offering scalable solutions for treating complex neurological conditions.

This remarkable achievement positions Indian healthcare research as a leader in developing transformative, next-generation medical solutions, opening doors for further advancements in brain-targeted therapies.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!